Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.70% to $511.74 Monday, on what proved to be an all-around great trading ...

So, I would expect Vertex's annual revenue to continue to climb significantly higher over the coming decade, and share performance should follow. This biotech is on track to be on top of its game in ...

Swiss National Bank raised its stake in Vertex, Inc. (NASDAQ:VERX – Free Report) by 7.3% during the 4th quarter, ...

Learn more about whether Elastic N.V. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Open Text Corporation or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, ...

In a regulatory filing, Vertex Pharmaceuticals (VRTX) chief scientific officer David Altshuler disclosed the sale of 3,231 common shares of the ...

Vertex Securities Limited is an India-based company, which offers comprehensive brokerage services across various financial segments, including equity, equity derivatives, currency derivatives ...

Vertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.13 per share a year ago. These figures ...

The Zacks Consensus Estimate for Vertex’s fourth-quarter 2024 earnings is pegged at 14 cents per share, implying a year-over-year increase of 7.7%. Vertex’s earnings surpassed the Zacks ...

I’ll now share a few key new business wins from the fourth quarter. Our ability to win when sophisticated market leaders are modernizing their indirect tax platform validates that Vertex’s ...